ethyl 3-methyl-3H-naphth[2,3-e]indole-2-carboxylate | 113516-80-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 蒽
• 英文名称: ethyl 3-methyl-3H-naphth[2,3-e]indole-2-carboxylate
• 英文别名: Ethyl 3-methyl-3H-naphtho[2,3-E]indole-2-carboxylate；ethyl 3-methylnaphtho[2,3-e]indole-2-carboxylate
• CAS: 113516-80-6
• 化学式: C₂₀H₁₇NO₂
• 分子量: 303.36
• InChiKey: AIURBHMEIISBIU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.8
• 重原子数：
  23
• 可旋转键数：
  3
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.15
• 拓扑面积：
  31.2
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  硫酸二甲酯 、 ethyl 3H-naphth[2,3-e]indole-2-carboxylate 以 ethyl acetate n-hexane 为溶剂， 以gave a 97% yield of ethyl 3-methyl-3H-naphth[2,3-e]indole-2-carboxylate, mp 141°-144°, (EtOAc/hexane), (C,H,N)的产率得到ethyl 3-methyl-3H-naphth[2,3-e]indole-2-carboxylate
  参考文献：
  名称：

  Tetracyclic heterocyclic derivatives, pharmaceutical compositions and use

  摘要：

  本发明涉及化合物式（I）ArCH.sub.2R.sup.1（I）或其单甲基或单乙基醚（式（I）的化合物包括这些醚，总碳原子数不超过29）；它们的醚，酯；酸加成盐；其中Ar是由5元环和6元环组成的融合四环芳香环系，含有至少一个杂原子和3个芳香环，环原子总数不超过18个，或其取代衍生物；杂原子最好是氧、硫或氮；当它是氮时，它被氢、甲基或乙基取代；R.sup.1含有不超过8个碳原子，是一个基团##STR1##其中m为0或1；R.sup.5是氢；R.sup.6和R.sup.7相同或不同，每个都是氢或C.sub.1-5烷基，可选地被羟基取代；R.sup.8和R.sup.9相同或不同，每个都是氢或C.sub.1-3烷基；##STR2##是一个五元环或六元环饱和碳环；R.sup.10是氢、甲基或羟甲基；R.sup.11、R.sup.12和R.sup.13相同或不同，每个都是氢或甲基；R.sup.14是氢、甲基、羟基或羟甲基。

  公开号：

  US04999369A1

文献信息

• Phenanthro[2,3-6]thiophene derivatives, pharmaceutical compositions and
  申请人：Burroughs Wellcome Co.

  公开号：US04910218A1

  公开（公告）日：1990-03-20

  The present invention relates to anti tumor compounds of formula (I) ArCH.sub.2 R.sup.1 (I) or a monomethyl or monoethyl ether thereof (the compound of formula (I) including these ethers may contain no more than 29 carbon atoms in total); ethers, esters thereof; acid addition salts thereof; wherein Ar is a fused tetracyclic aromatic ring system comprised of 5-membered and 6-membered rings and contains at least one heteroatom and 3 aromatic rings and a total of no more than 18 ring atoms, or a substituted derivative thereof; the heteroatom is preferably oxygen, sulfur or nitrogen; when it is nitrogen this is substituted by hydrogen, methyl or ethyl; R.sup.1 contains not more than eight carbon atoms and is a group ##STR1## wherein m is 0 or 1; R.sup.5 is hydrogen; R.sup.6 and R.sup.7 are the same or different and each is hydrogen or C.sub.1-5 alkyl optionally substituted by hydroxy; R.sup.8 and R.sup.9 are the same or different and each is hydrogen or C.sub.1-3 alkyl; ##STR2## is a five or six-membered saturated carbocyclic ring; R.sup.10 is hydrogen, methyl or hydroxymethyl; R.sup.11, R.sup.12 and R.sup.13 are the same or different and each is hydrogen or methyl; R.sup.14 is hydrogen, methyl, hydroxy, or hydroxymethyl.

  本发明涉及式（I）ArCH.sub.2 R.sup.1（I）或其单甲基或单乙基醚（式（I）的化合物包括这些醚，总碳原子数不超过29）的抗肿瘤化合物；它们的醚，酯；酸加成盐；其中Ar是由5元环和6元环组成的融合四环芳香环系统，并含有至少一个杂原子和3个芳香环，总环原子数不超过18，或其取代衍生物；杂原子最好是氧、硫或氮；当它是氮时，被氢、甲基或乙基取代；R.sup.1含有不超过八个碳原子，是一个组##STR1##其中m为0或1；R.sup.5为氢；R.sup.6和R.sup.7相同或不同，每个都是氢或C.sub.1-5烷基，可选择地被羟基取代；R.sup.8和R.sup.9相同或不同，每个都是氢或C.sub.1-3烷基；##STR2##是一个五元或六元饱和碳环；R.sup.10为氢、甲基或羟甲基；R.sup.11、R.sup.12和R.sup.13相同或不同，每个都是氢或甲基；R.sup.14为氢、甲基、羟基或羟甲基。
• Heteropolycyclic aromatic compounds
  申请人：THE WELLCOME FOUNDATION LIMITED

  公开号：EP0246077A1

  公开（公告）日：1987-11-19

  The present invention relates to compounds of the formula (I) ArCH₂NHR¹ (I) or a monomethyl or monoethyl ether thereof, the compound of formula (I) including the said ethers containing no more than 29 carbon atoms in total; an ester thereof; a salt thereof; wherein Ar is a ring system of formula wherein is a five-membered ring containing at least one heteroatom and two double bonds or a substituted derivative thereof or a resonance form thereof, the heteratom is preferably oxygen, sulphur or nitrogen substituted by hydrogen methyl or ethyl; R¹ contains not more than eight carbon atoms and is a group wherein m is 0 or 1; R⁵ and R⁶ are the same or different and each is hydrogen or C1-3 alkyl optionally substituted by hydroxy; R⁷ and R⁸ are the same or different and each is hydrogen or C1-3 alkyl; -C-C is a five-or six-membered saturated carbocyclic ring; R⁹ is hydrogen, methyl or hydroxymethyl; R¹⁰, R¹¹ and R¹² are the same or different and each is hydrogen or methyl; R¹³ is hydrogen, methyl, hydroxy or hydroxymethyl.

  本发明涉及式 (I) 的化合物 ArCH₂NHR¹ (I) 或其单甲基或单乙基醚，式(I)化合物包括总共含有不超过 29 个碳原子的上述醚；其酯；其盐； 其中 Ar 为式的环系 其中 是含有至少一个杂原子和两个双键的五元环或其取代衍生物或其共振形式，杂原子最好是被甲基氢或乙基氢取代的氧、硫或氮； R¹ 含有不超过 8 个碳原子并且是一个基团 其中 m 为 0 或 1； R⁵ 和 R⁶ 可以相同或不同，并且各自为氢或任选被羟基取代的 C1-3 烷基； R⁷ 和 R⁸ 相同或不同，且各自为氢或 C1-3 烷基； -C-C是五元或六元饱和碳环； R𠞙 是氢、甲基或羟甲基； R¹⁰、R¹¹和R¹²相同或不同，且各自为氢或甲基； R¹³ 是氢、甲基、羟基或羟甲基。
• US4910218A
  申请人：——

  公开号：US4910218A

  公开（公告）日：1990-03-20
• US4999369A
  申请人：——

  公开号：US4999369A

  公开（公告）日：1991-03-12
• Tetracyclic heterocyclic derivatives, pharmaceutical compositions and use
  申请人：Burroughs Wellcome Co.

  公开号：US04999369A1

  公开（公告）日：1991-03-12

  The present invention relates to compounds of formula (I) ArCH.sub.2 R.sup.1 (I) or a monomethyl or monoethyl ether thereof (the compound of formula (I) including these ethers may contain no more than 29 carbon atoms in total); ethers, esters thereof; acid addition salts thereof; wherein Ar is a fused tetracyclic aromatic ring system comprised of 5-membered and 6-membered rings and contains at least one heteroatom and 3 aromatic rings and a total of no more than 18 ring atoms, or a substituted derivative thereof; the heteroatom is preferably oxygen, sulfur or nitrogen; when it is nitrogen this is substituted by hydrogen, methyl or ethyl; R.sup.1 contains not more than eight carbon atoms and is a group ##STR1## wherein m is 0 or 1; R.sup.5 is hydrogen; R.sup.6 and R.sup.7 are the same or different and each is hydrogen or C.sub.1-5 alkyl optionally substituted by hydroxy; R.sup.8 and R.sup.9 are the same or different and each is hydrogen or C.sub.1-3 alkyl; ##STR2## is a five or six-membered saturated carbocyclic ring; R.sup.10 is hydrogen, methyl or hydroxymethyl; R.sup.11, R.sup.12 and R.sup.13 are the same or different and each is hydrogen or methyl; R.sup.14 is hydrogen, methyl, hydroxy, or hydroxymethyl.

  本发明涉及化合物式（I）ArCH.sub.2R.sup.1（I）或其单甲基或单乙基醚（式（I）的化合物包括这些醚，总碳原子数不超过29）；它们的醚，酯；酸加成盐；其中Ar是由5元环和6元环组成的融合四环芳香环系，含有至少一个杂原子和3个芳香环，环原子总数不超过18个，或其取代衍生物；杂原子最好是氧、硫或氮；当它是氮时，它被氢、甲基或乙基取代；R.sup.1含有不超过8个碳原子，是一个基团##STR1##其中m为0或1；R.sup.5是氢；R.sup.6和R.sup.7相同或不同，每个都是氢或C.sub.1-5烷基，可选地被羟基取代；R.sup.8和R.sup.9相同或不同，每个都是氢或C.sub.1-3烷基；##STR2##是一个五元环或六元环饱和碳环；R.sup.10是氢、甲基或羟甲基；R.sup.11、R.sup.12和R.sup.13相同或不同，每个都是氢或甲基；R.sup.14是氢、甲基、羟基或羟甲基。